Uncategorized

18
Jul

Enhancing Fibrotic Lung Research: How baseclick’s Sugar-Ligand Technology Advances Drug Targeting

Pulmonary fibrosis remains one of the most challenging and poorly treatable chronic diseases. Despite promising in vitro findings, many anti-fibrotic compounds fail in clinical translation
MORE →
2
Jul

Upcoming Webinar: Solving Nucleic Acid Sequencing Challenges: ClickSeq Applications in RNA & DNA Library Preparation

We are pleased to invite you to our upcoming webinar featuring the latest advancements in ClickSeq technology, a click-chemistry-driven platform for RNA and now DNA
MORE →
24
Jun

Novartis Acquires Regulus Therapeutics to Advance microRNA-Based Therapy for ADPKD

Novartis has announced its acquisition of Regulus Therapeutics in a transaction valued at up to $1.7 billion. This strategic move aims to advance farabursen, an
MORE →
6
Jun

baseclick GmbH secures revolutionary U.S. Patent for Click modified mRNA Technology

Development of innovative platform enhances mRNA therapeutics with improved stability, targeting and delivery Neuried, Germany (June 06, 2025) baseclick GmbH, a leader in nucleic acid
MORE →
20
May

New Product Launch: DNA-ClickSeq Library Prep Kit

baseclick GmbH and ClickSeq Technologies are excited to announce the launch of our DNA-ClickSeq Library Prep Kit. This new product expands our portfolio of innovative
MORE →